₹ 1,575.50
-20.40 (-1.28%)
N
Novartis
₹ 1,575.50
NOVARTIND Fundamentals
Company Valuation
Market Cap (₹ Cr.)
3,890
PE Ratio
40.30
PB Ratio
4.82
Dividend Yield
1.57%
ROE
12.85%
ROCE
16.28%
Book Value (₹)
331.23
Face Value (₹)
5.00
Analyse NOVARTIND with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Promoters | 70.68% | 70.68% | 70.68% | 70.68% | 70.68% |
| Domestic Institutional Investors (DII) | 0.53% | 0.53% | 0.64% | 0.53% | 1.36% |
| Foreign Institutional Investors (FII) | 0.19% | 0.19% | 0.19% | 0.17% | 0.16% |
| Public Investors | 22.95% | 22.92% | 22.67% | 23.25% | 22.50% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
NOVARTIND Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
500672
NSE Scrip Name
NOVARTIND
ISIN
INE234A01025



